The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties

por Nakai, Kiyohiko, Tobinai, Masato, Hashimoto, Junko, Iida, Satofumi, Kawanishi, Takehiko
Publicado 2014

Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS...

por Ohmachi, Ken, Ando, Kiyoshi, Kinoshita, Tomohiro, Kumagai, Kyoya, Hatake, Kiyohiko, Ishikawa, Takayuki, Teshima, Takanori, Kato, Koji, Izutsu, Koji, Ueda, Eisuke, Nakai, Kiyohiko, Kuriki, Hiroshi, Tobinai, Kensei
Publicado 2018

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with...

por Ebata, Takahiro, Shimizu, Toshio, Fujiwara, Yutaka, Tamura, Kenji, Kondo, Shunsuke, Iwasa, Satoru, Yonemori, Kan, Shimomura, Akihiko, Kitano, Shigehisa, Koyama, Takafumi, Sato, Natsuko, Nakai, Kiyohiko, Inatani, Michiyasu, Yamamoto, Noboru
Publicado 2019